JP2011500757A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011500757A5 JP2011500757A5 JP2010530429A JP2010530429A JP2011500757A5 JP 2011500757 A5 JP2011500757 A5 JP 2011500757A5 JP 2010530429 A JP2010530429 A JP 2010530429A JP 2010530429 A JP2010530429 A JP 2010530429A JP 2011500757 A5 JP2011500757 A5 JP 2011500757A5
- Authority
- JP
- Japan
- Prior art keywords
- resin
- protein
- containing protein
- affinity chromatography
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 claims 27
- 102000004169 proteins and genes Human genes 0.000 claims 13
- 108090000623 proteins and genes Proteins 0.000 claims 13
- 239000011347 resin Substances 0.000 claims 8
- 229920005989 resin Polymers 0.000 claims 8
- 238000001042 affinity chromatography Methods 0.000 claims 7
- 229920001184 polypeptide Polymers 0.000 claims 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 6
- 108091006020 Fc-tagged proteins Proteins 0.000 claims 5
- 239000001045 blue dye Substances 0.000 claims 5
- 239000012539 chromatography resin Substances 0.000 claims 4
- 229920002684 Sepharose Polymers 0.000 claims 3
- 239000003446 ligand Substances 0.000 claims 3
- 239000007788 liquid Substances 0.000 claims 3
- 235000011164 potassium chloride Nutrition 0.000 claims 3
- 239000001103 potassium chloride Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 108060003951 Immunoglobulin Proteins 0.000 claims 2
- 102000008300 Mutant Proteins Human genes 0.000 claims 2
- 108010021466 Mutant Proteins Proteins 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims 2
- 238000004587 chromatography analysis Methods 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 102000018358 immunoglobulin Human genes 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 102000003298 tumor necrosis factor receptor Human genes 0.000 claims 2
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 208000002109 Argyria Diseases 0.000 claims 1
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims 1
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims 1
- 101000795167 Homo sapiens Tumor necrosis factor receptor superfamily member 13B Proteins 0.000 claims 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 claims 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 claims 1
- 102100026720 Interferon beta Human genes 0.000 claims 1
- 108090000467 Interferon-beta Proteins 0.000 claims 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- 102100040247 Tumor necrosis factor Human genes 0.000 claims 1
- 102100029675 Tumor necrosis factor receptor superfamily member 13B Human genes 0.000 claims 1
- 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 claims 1
- 101710178300 Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 claims 1
- 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 claims 1
- 101710187743 Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 claims 1
- 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 claims 1
- 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- YKCWQPZFAFZLBI-UHFFFAOYSA-N cibacron blue Chemical compound C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S(O)(=O)=O)C=C1NC(C=C1S(O)(=O)=O)=CC=C1NC(N=1)=NC(Cl)=NC=1NC1=CC=CC=C1S(O)(=O)=O YKCWQPZFAFZLBI-UHFFFAOYSA-N 0.000 claims 1
- 239000000975 dye Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 claims 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims 1
- 238000004255 ion exchange chromatography Methods 0.000 claims 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 235000017281 sodium acetate Nutrition 0.000 claims 1
- 239000001632 sodium acetate Substances 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims 1
- 238000000108 ultra-filtration Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07118983 | 2007-10-22 | ||
| US722307P | 2007-12-11 | 2007-12-11 | |
| PCT/EP2008/064210 WO2009053360A1 (en) | 2007-10-22 | 2008-10-21 | Method for purifying an fc-containing protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011500757A JP2011500757A (ja) | 2011-01-06 |
| JP2011500757A5 true JP2011500757A5 (enExample) | 2011-12-08 |
Family
ID=38961834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010530429A Withdrawn JP2011500757A (ja) | 2007-10-22 | 2008-10-21 | Fc含有タンパク質の精製方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100256337A1 (enExample) |
| EP (1) | EP2203465A1 (enExample) |
| JP (1) | JP2011500757A (enExample) |
| AU (1) | AU2008314689A1 (enExample) |
| CA (1) | CA2701221A1 (enExample) |
| IL (1) | IL204949A0 (enExample) |
| WO (1) | WO2009053360A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE038947T2 (hu) | 2005-08-26 | 2018-12-28 | Ares Trading Sa | Eljárás glikozilált béta-interferon elõállítására |
| WO2009053358A1 (en) * | 2007-10-22 | 2009-04-30 | Merck Serono S.A. | Method for purifying fc-fusion proteins |
| JP5728392B2 (ja) | 2009-03-05 | 2015-06-03 | バイオジェン アイデック エムエー インコーポレイティドBiogen Idec Inc. | 免疫グロブリンの精製 |
| JP6026002B2 (ja) * | 2012-11-27 | 2016-11-16 | アルテオジェン インコーポレイテッド | タンパク質とFcドメインを融合した融合タンパク質の安定化用組成物 |
| KR20160119134A (ko) * | 2014-02-04 | 2016-10-12 | 바스프 에스이 | 특이적 안트라퀴논 염료-리간드 구조를 사용한 항체, 항체 단편 또는 이들의 조작된 변이체의 정제 방법 |
| EP2918641A1 (en) * | 2014-03-13 | 2015-09-16 | Basf Se | Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures |
| BR112016029157A8 (pt) | 2014-06-13 | 2021-07-06 | Lupin Ltd | processo para purificar a proteína de fusão tnfr:fc |
| US9821059B2 (en) | 2014-10-17 | 2017-11-21 | Alteogen Inc. | Composition for stabilizing protein and pharmaceutical formulation comprising the same |
| CN115812077A (zh) | 2020-05-08 | 2023-03-17 | 高山免疫科学股份有限公司 | April和baff抑制性免疫调节蛋白及其使用方法 |
| CN120904317A (zh) * | 2025-09-28 | 2025-11-07 | 中国医学科学院输血研究所 | 一种两步亲和层析法制备犬用免疫球蛋白的方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4966843A (en) * | 1982-11-01 | 1990-10-30 | Cetus Corporation | Expression of interferon genes in Chinese hamster ovary cells |
| ATE148171T1 (de) * | 1989-02-21 | 1997-02-15 | Univ Washington | Modifizierte formen von fortpflanzungshormonen |
| US5338835A (en) * | 1989-02-21 | 1994-08-16 | Washington University | CTP-extended form of FSH |
| SG63617A1 (en) | 1991-01-18 | 1999-03-30 | Amgen Boulder Inc | Methods for treating tumar necrosis factor mediated diseases |
| US5508261A (en) * | 1991-06-18 | 1996-04-16 | University Of Medicine & Dentistry Of New Jersey | Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same |
| SE9201073D0 (sv) * | 1992-04-03 | 1992-04-03 | Kabi Pharmacia Ab | Protein formulation |
| US6162905A (en) * | 1996-11-07 | 2000-12-19 | Ibsa Institut Biochimique S.A. | FSH and LH separation and purification process |
| US5883073A (en) * | 1997-04-03 | 1999-03-16 | Washington University | Single-chain double-alpha peptide |
| US5990288A (en) * | 1997-10-21 | 1999-11-23 | Vitro Diagnostics, Inc. | Method for purifying FSH |
| US7431921B2 (en) * | 1999-08-27 | 2008-10-07 | Maxygen Aps | Interferon beta-like molecules |
| EP1261622B1 (en) * | 2000-02-22 | 2007-03-07 | Applied Research Systems ARS Holding N.V. | Purified recombinant hlh having a specific bioactivity and process for purification thereof |
| CA2405550A1 (en) * | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US20030017550A1 (en) * | 2001-01-22 | 2003-01-23 | Pang Danny Zhong Der | DNA sequences encoding fusion proteins comprising IFN-beta and TM-alpha1 |
| US7226903B2 (en) * | 2001-10-10 | 2007-06-05 | Neose Technologies, Inc. | Interferon beta: remodeling and glycoconjugation of interferon beta |
| AU2002364586A1 (en) * | 2001-12-21 | 2003-07-30 | Delta Biotechnology Limited | Albumin fusion proteins |
| TWI353991B (en) * | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| ES2333128T3 (es) * | 2003-12-22 | 2010-02-17 | Ares Trading S.A. | Metodo para purificar fsh. |
| SI1809663T1 (sl) * | 2004-11-09 | 2009-02-28 | Ares Trading Sa | Postopek za äśiĺ äśenje fsh |
| HUE038947T2 (hu) * | 2005-08-26 | 2018-12-28 | Ares Trading Sa | Eljárás glikozilált béta-interferon elõállítására |
| US8604175B2 (en) * | 2005-12-09 | 2013-12-10 | Ares Trading S.A. | Method for purifying FSH or a FSH mutant |
| EP1981908B1 (en) * | 2006-01-17 | 2010-11-10 | Merck Serono SA | Novel fsh glycosylation variant d3n |
| WO2009053358A1 (en) * | 2007-10-22 | 2009-04-30 | Merck Serono S.A. | Method for purifying fc-fusion proteins |
-
2008
- 2008-10-21 JP JP2010530429A patent/JP2011500757A/ja not_active Withdrawn
- 2008-10-21 WO PCT/EP2008/064210 patent/WO2009053360A1/en not_active Ceased
- 2008-10-21 EP EP08841851A patent/EP2203465A1/en not_active Withdrawn
- 2008-10-21 US US12/738,515 patent/US20100256337A1/en not_active Abandoned
- 2008-10-21 CA CA2701221A patent/CA2701221A1/en not_active Abandoned
- 2008-10-21 AU AU2008314689A patent/AU2008314689A1/en not_active Abandoned
-
2010
- 2010-04-08 IL IL204949A patent/IL204949A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011500757A5 (enExample) | ||
| ES2322945T5 (es) | Métodos para purficación de proteína | |
| JP6544809B2 (ja) | 突然変異免疫グロブリン結合ポリペプチド | |
| JP6420756B2 (ja) | アフィニティークロマトグラフィーマトリックス | |
| ES2812648T3 (es) | Eliminación de agregados de proteína de preparaciones biofarmacéuticas en un modo de flujo continuo | |
| CN103269761B (zh) | 亲和色谱基质 | |
| JP6285532B2 (ja) | タンパク質aに基づくクロマトグラフィを使用するタンパク質純度を増加させる方法 | |
| CN102712673B (zh) | 用于纯化含fc的蛋白的色谱方法 | |
| JP6093772B2 (ja) | タンパク質の混合モードクロマトグラフィー精製用の固相 | |
| JP2019034963A (ja) | 陽イオン交換基を用いた新規抗体精製法(Novel Antibody Purification method using Cation Exchanger) | |
| RS61881B1 (sr) | Novi hibridni actriib proteini zamke za ligand za lečenje bolesti gubljenja mišića | |
| CN107001432A (zh) | 突变的免疫球蛋白结合多肽 | |
| JP2011526792A5 (enExample) | ||
| KR20130131307A (ko) | 단백질 정제 | |
| ME01198B (me) | Prečišćavanje il-18 vezujućeg proteina | |
| CN105777904A (zh) | 抗TNFα类单克隆抗体的阳离子交换色谱纯化方法 | |
| WO2014034457A1 (ja) | ミックスモード抗体アフィニティー分離マトリックスとそれを用いた精製方法および標的分子 | |
| EP1891088B1 (en) | Process for the purification of il-18 binding protein | |
| CN106414495A (zh) | 抗体处理方法 | |
| Yu et al. | Paper‐PEG‐based membranes for hydrophobic interaction chromatography: Purification of monoclonal antibody | |
| CN105777903B (zh) | 一种阿达木单抗的阳离子交换色谱纯化方法 | |
| RU2670166C1 (ru) | Способ получения слитого белка tnfr-fc с заданным содержанием примесей | |
| Guo | Bioprocess Development for Recombinant Therapeutic Protein Osteopontin from Escherichia Coli | |
| HK1174044B (en) | Chromatographic method for purifying fc-containing proteins | |
| JP2013184919A (ja) | 精製方法 |